Stock analysts at StockNews.com began coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock. Cancer Genetics Stock Down 2.3 % Shares of NASDAQ CGIX opened at $4.61 on Friday. Cancer Genetics has a twelve month low of $2.11 […]